Merger Model Accretion Dilution: Does the Deal Add EPS?

Key Takeaways

• Merger model accretion dilution analysis compares the after-tax earnings the acquirer gains from the target against the after-tax cost of cash, debt, and new equity used to fund the purchase price.
• A deal where the acquirer issues shares at a 20x P/E to buy a target at 15x is accretive because the acquirer's earnings yield (5 percent) exceeds the target's earnings yield (6.7 percent), the high-P/E buyer has the easier math.
• The most common omission is ignoring the step-up in depreciation and amortization from purchase accounting, which reduces reported EPS and can flip an apparently accretive deal to dilutive.
• Accretion is not value creation, an acquirer can pay more than the combined intrinsic value and still show EPS accretion in year one, making the EPS test a necessary but insufficient check on deal quality.

What It Is

The merger model, also called an accretion/dilution model or M&A model, projects a combined company after the transaction closes. The acquirer pays a premium over the target's unaffected share price, funds that premium with cash, new debt, stock, or a mix, and absorbs the target's earnings, interest, and taxes.

The headline output is the percentage change in EPS:

EPS accretion or dilution = (Pro forma EPS / Standalone acquirer EPS) - 1

A positive number is accretion. A negative number is dilution. Boards generally prefer accretive deals in year one or two because the market tends to punish dilution.

The Intuition

Accretion/dilution comes down to a simple comparison. Does the after-tax income the acquirer gains from the target exceed the after-tax cost of the financing used to pay for it?

Cash deals are cheap because foregone interest on cash (at maybe 4 to 5 percent after tax today) is a small cost. Debt deals are moderately priced because interest is tax-deductible. Stock deals are expensive because the acquirer's earnings yield (inverse of its P/E) sets the implicit cost. A company trading at 25x earnings has a 4 percent earnings yield. A company trading at 15x has a 6.7 percent earnings yield. The lower earnings yield (higher P/E) buyer generally has an easier time creating accretion.

How It Works

Six inputs drive the result:

1. Offer price. Per-share price, usually a 20 to 40 percent premium to the target's unaffected price.
2. Financing mix. Cash on hand, new debt (at an assumed rate), new equity issuance (at an assumed share price).
3. Target net income. Projected pro forma contribution.
4. Synergies. Run-rate cost savings or revenue lift, phased in over one to three years, after tax.
5. Deal adjustments. Incremental interest expense on new debt, foregone interest on cash used, amortization of newly identified intangibles.
6. New share count. Acquirer shares plus any shares issued to fund the deal.

The formula for pro forma EPS:

Pro forma net income =
    acquirer NI
  + target NI
  + after-tax synergies
  - after-tax new interest
  - after-tax foregone interest on cash
  - after-tax amortization of new intangibles

Pro forma EPS = pro forma NI / pro forma share count

Worked Example

Acquirer standalone: $500 million net income, 100 million shares, so $5.00 EPS. Stock trades at $100 (20x P/E).

Target: $100 million net income. Offer price $3.0 billion, paid with $1.5 billion cash (previously yielding 4 percent), $1.0 billion new debt (at 6 percent), and $500 million in new stock (5 million shares issued at $100).

Tax rate 25 percent. Synergies of $50 million run-rate, fully phased in year 1.

Target NI contribution                      +100
After-tax synergies (50 x 0.75)              +38
After-tax foregone interest
    (1,500 x 4% x 0.75)                     -45
After-tax new interest
    (1,000 x 6% x 0.75)                     -45
Net income added                             +48

Pro forma NI = 500 + 48 = 548
New share count = 100 + 5 = 105
Pro forma EPS  = 548 / 105 = 5.22

Accretion = (5.22 / 5.00) - 1 = +4.3 percent

The deal is accretive. If the acquirer traded at 10x (EPS yield 10 percent) rather than 20x, the new shares would contribute less earnings per share and dilution would be more likely.

Common Mistakes

1. Mixing pre-tax and after-tax figures. Synergies, foregone interest, and new interest all have to be put on the same tax basis. A common error is netting pre-tax synergy against after-tax financing cost, which flatters accretion.

2. Ignoring the step-up in depreciation and amortization. Purchase accounting writes up fixed assets and creates new intangibles. The extra amortization is tax-deductible but reduces reported EPS. Leaving it out is the single most frequent omission.

3. Using the acquirer's current share price for stock consideration. The deal announcement itself tends to push the acquirer's stock down. A better model uses a blended price or sensitizes on it, rather than locking the transaction at today's quote.

4. Treating synergies as instant. Cost synergies typically phase in over 18 to 36 months and come with one-time restructuring charges. Modeling 100 percent of run-rate in year 1 and zero restructuring is too optimistic.

5. Confusing accretion with value creation. An accretive deal can still destroy value if the price paid exceeds the intrinsic value of the target plus synergies. EPS impact and net present value are separate tests.

Frequently Asked Questions

Q: What is merger model accretion dilution in simple terms? Accretion dilution analysis calculates whether a deal raises or lowers the acquirer's earnings per share. If pro forma EPS is higher than the acquirer's standalone EPS, the deal is accretive; if lower, it is dilutive.

Q: How does merger model accretion dilution affect investment decisions? Boards and investors use it as a first screen. A dilutive deal requires a compelling strategic or synergy justification to proceed. An accretive deal is easier to approve but still needs to pass an intrinsic-value test separately.

Q: What is a real-world example of merger model accretion dilution? An acquirer with $5.00 EPS buys a target for $3 billion using $1.5B cash, $1B debt, and $0.5B stock. After netting foregone interest income, new interest expense, synergies, and new shares, pro forma EPS rises to $5.22, accretion of 4.3 percent.

Q: How can investors use or avoid merger model errors? Investors should verify that synergies are fully phased in over 18 to 36 months, not recognized on day one, and that the purchase accounting step-up in D&A is included in the model. Both adjustments commonly flip an accretive-looking deal into dilution in year one.

Q: How is merger model accretion dilution different from an NPV analysis of a deal? Accretion dilution measures EPS impact, which depends on accounting choices and synergy timing. NPV measures whether the price paid is less than the intrinsic value gained. A deal can be EPS-accretive but value-destroying if the premium paid exceeds the synergies created.

Sources

1. Wall Street Prep. "Merger Model, M&A Training Tutorial and Excel Template." https://www.wallstreetprep.com/knowledge/merger-model/
2. Wall Street Prep. "Accretion/Dilution Analysis." https://www.wallstreetprep.com/knowledge/financial-modeling-quick-lesson-accretion-dilution-model/
3. Wall Street Prep. "Deal Accounting in Simple English." https://www.wallstreetprep.com/knowledge/ma-accounting-in-simple-english/
4. Corporate Finance Institute. "Accretion Dilution Analysis." https://corporatefinanceinstitute.com/resources/financial-modeling/accretion-dilution-analysis/

Disclaimer

This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.